Neurocrine Biosciences, Inc. (NBIX)
157.61
+0.85
(+0.54%)
USD |
NASDAQ |
Sep 02, 14:39
Neurocrine Biosciences Net Income (TTM) : 705.50M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 705.50M |
| March 31, 2026 | 668.60M |
| December 31, 2025 | 478.60M |
| September 30, 2025 | 428.00M |
| June 30, 2025 | 348.30M |
| March 31, 2025 | 305.80M |
| December 31, 2024 | 341.30M |
| September 30, 2024 | 385.90M |
| June 30, 2024 | 339.20M |
| March 31, 2024 | 369.70M |
| December 31, 2023 | 249.70M |
| September 30, 2023 | 191.00M |
| June 30, 2023 | 176.40M |
| March 31, 2023 | 64.00M |
| December 31, 2022 | 154.50M |
| September 30, 2022 | 58.20M |
| June 30, 2022 | 12.20M |
| March 31, 2022 | 71.40M |
| December 31, 2021 | 89.60M |
| September 30, 2021 | 444.80M |
| June 30, 2021 | 364.70M |
| March 31, 2021 | 402.00M |
| December 31, 2020 | 407.30M |
| September 30, 2020 | 93.40M |
| June 30, 2020 | 204.79M |
| Date | Value |
|---|---|
| March 31, 2020 | 176.53M |
| December 31, 2019 | 37.01M |
| September 30, 2019 | 21.09M |
| June 30, 2019 | 18.06M |
| March 31, 2019 | -39.19M |
| December 31, 2018 | 21.11M |
| September 30, 2018 | 9.927M |
| June 30, 2018 | -51.96M |
| March 31, 2018 | -106.03M |
| December 31, 2017 | -142.54M |
| September 30, 2017 | -194.10M |
| June 30, 2017 | -219.86M |
| March 31, 2017 | -200.15M |
| December 31, 2016 | -141.09M |
| September 30, 2016 | -125.75M |
| June 30, 2016 | -123.29M |
| March 31, 2016 | -107.00M |
| December 31, 2015 | -88.93M |
| September 30, 2015 | -79.06M |
| June 30, 2015 | -60.50M |
| March 31, 2015 | -49.89M |
| December 31, 2014 | -60.54M |
| September 30, 2014 | -51.74M |
| June 30, 2014 | -47.00M |
| March 31, 2014 | -45.86M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Amarin Corp. Plc | -27.07M |
| Liquidia Corp. | 138.61M |
| Incyte Corp. | 1.612B |
| Halozyme Therapeutics, Inc. | 413.60M |
| Iovance Biotherapeutics, Inc. | -289.52M |